| 177Lu-DOTA-TATE | [177Lu]Lu[DOTA0-Tyr3]octreotate |
| BSA | Bovine serum albumin |
| γH2AX | Phosphorylated histone 2A |
| DAPI | 4’,6-diamidino-2-phenylindole |
| DSB | Double strand break |
| DMSO | Dimethyl sulfoxide |
| GEP-NETs | Gastroenteropancreatic-neuroendocrine tumors |
| HBSS | Hanks balanced salt solution |
| IF | Immunofluorescent |
| NETs | Neuroendocrine tumors |
| PARP | Poly(ADP-ribose)-polymerase |
| PARPi | Poly(ADP-ribose)-polymerase inhibitor |
| PBS | Phosphate buffered saline |
| PBST | Phosphate buffered saline containing Triton X-100 |
| PEG300 | Polyethylene glycol 300 |
| P-gp | P-glycoprotein efflux pump |
| P.i. | Post-injection |
| PRRT | Peptide receptor radionuclide therapy |
| SSB | Single strand break |
| SSTR2 | Somatostatin receptor subtype 2 |
| TTP | Time to progression |
| UPLC-MS/MS | Ultra performance liquid chromatography-tandem mass spectrometer |